Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplasms
×
sargramostim
×
Clear all
Filters
3
NCT01784913
2024-12-16
UV1/hTERT2012P
Ultimovacs ASA
Phase 1/2
Completed
22 enrolled
NCT01480479
2018-01-16
ACT IV
Celldex Therapeutics
Phase 3
Completed
745 enrolled